In the article on how EGFR enhances motility and intravasation in vivo in the January 1, 2006 issue of Cancer Research (1), in Fig. 1A, the label reading “α-ErbB4” should have read “α-actin.” The corrected figure appears below.

1
Xue C, Wyckoff J, Liang F, Sidani M, Violini S, Tsai K-L, Zhang Z-Y, Sahai E, Condeelis J, Segall JE. Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis.
Cancer Res
2006
;
66
:
192
–7.